Učitavanje...
von Willebrand factor–cleaving protease ADAMTS13 reduces ischemic brain injury in experimental stroke
Stroke is a leading cause of death and disability. The only therapy available is recombinant tissue plasminogen activator, but side effects limit its use. Platelets play a crucial role during stroke, and the inflammatory reaction promotes neurodegeneration. von Willebrand factor (VWF), an adhesion m...
Spremljeno u:
| Glavni autori: | , , , , , , , |
|---|---|
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
American Society of Hematology
2009
|
| Teme: | |
| Online pristup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2759655/ https://ncbi.nlm.nih.gov/pubmed/19687510 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1182/blood-2009-03-213264 |
| Oznake: |
Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!
|